migraine
Neurology · 2009–2024
4decisions
3medicines
1carried consumer input
54individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| rimegepant Acute treatment of migraine attacks in adult patients who have not responded adequately, are intolerant or contraindicated to analgesics and at least two… | Mar 2024 | Not recommended | 54 individuals Headache Australia · Pain Australia |
| eletriptan hydrobromide treatment of migraine attacks in patients where past attacks have usually failed to respond to analgesics | Mar 2010 | Recommended with restriction | no section in document |
| eletriptan hydrobromide Acute treatment of migraine attacks in patients where attacks in the past have usually failed to respond to analgesics. | Mar 2010 | Recommended with restriction | no section in document |
| rizatriptan benzoate Acute treatment of migraine attacks, with or without aura. | Nov 2009 | Recommended with restriction | no section in document |
Who spoke
Headache Australia · Pain Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.